Integrative Chiropractic Care Techniques for Relief from OUD

Understanding integrative chiropractic care for OUD is essential for enhancing the treatment of opioid use disorder in a holistic way.

Opioid use disorder (OUD) rewires neurocircuitry, disrupts autonomic regulation, and impairs physical function. For individuals navigating recovery, the intersection of chronic musculoskeletal pain, physical deconditioning, and neurochemical adaptation often forms a formidable barrier to lasting stability. While Medications for Opioid Use Disorder (MOUD)—particularly buprenorphine and methadone—remain the primary standard of care for stabilizing mu-opioid receptor dynamics and reducing mortality, pharmacotherapy alone rarely addresses the mechanical pain and somatic distress that drive initial opioid exposure or precipitate return to use.

Drawing from dual training in physical medicine and advanced nursing practice at Health Voice 360, clinical observations by Dr. Alexander Jimenez, DC, APRN, FNP-BC, demonstrate that integrating evidence-based chiropractic care with modern addiction medicine addresses these underlying biomechanical drivers. Restoring joint kinematics, modulating nociceptive input, and down-regulating central sensitization provide patients with a non-pharmacologic pathway to manage musculoskeletal pain and achieve long-term functional recovery.

Neurobiological and Biomechanical Interplay: Pain, Allostasis, and OUD

Understanding how physical medicine supports addiction recovery requires examining the shared neural architecture linking spinal biomechanics, nociception, and the brain’s reward centers.

Chronic Mechanical Nociception / Somatic Dysfunction
                      ?
                      ?
Dorsal Horn Sensitization & Sustained Sympathetic Tone
                      ?
                      ?
Ascending Projections to Thalamus, Limbic System & PAG
                      ?
                      ?
   Amplified Dysphoria, Stress Allostasis & Craving
                      ?
                      ?
   Targeted Chiropractic Spinal Manipulation & Mobilization
                      ?
                      ?
Proprioceptive Afferent Bombardment (Ia & II Mechanoreceptors)
                      ?
                      ?
Inhibition of Dorsal Horn Projection Neurons (Gate Control)
                      ?
                      ?
Reduced Allostatic Load & Restoration of Biomechanical Function

The Neuro-Somatic Cycle of Addiction and Pain

Chronic opioid exposure alters the central nervous system through allostatic neuroadaptation. As the mu-opioid system desensitizes, compensatory increases in corticotropin-releasing factor (CRF) and central noradrenergic tone create a baseline state of hyperarousal and somatic unease (Koob & Volkow, 2016). When patients experience opioid-induced hyperalgesia (OIH)—a neuroplastic state where opioid therapy paradoxically amplifies nociceptive sensitivity—everyday musculoskeletal stresses register as severe, intolerable pain.

Patients often become trapped in a self-reinforcing loop:

1. Biomechanical Strain: Poor posture, tissue trauma, or degenerative changes fire persistent nociceptive impulses.

2. Central Amplification: Sensitized dorsal horn neurons and an overactive limbic system magnify pain perception.

3. Autonomic Dysregulation: Elevated sympathetic tone increases myofascial tension and sleep disturbance.

4. Behavioral Coping: The patient experiences an acute craving for exogenous opioids to achieve temporary relief, risking return to use.

Mechanistic Impact of Chiropractic Adjustments

High-velocity, low-amplitude (HVLA) spinal manipulation and targeted articular mobilization interrupt this vicious cycle through mechanical and neurophysiological mechanisms:

• Segmental Gating and Afferent Bombardment: Spinal adjustment rapidly stretches capsular and paraspinal tissues, stimulating low-threshold type Ia and II mechanoreceptors and muscle spindle afferents. This flood of mechanoreceptive input inhibits nociceptive transmission at the substantia gelatinosa in the spinal dorsal horn, closing the neural gate to ascending pain signals (Pickar, 2002).

• Supraspinal Pain Modulation: Mechanical spinal adjustments modulate functional connectivity in brain regions dedicated to pain perception and affective processing, including the periaqueductal gray (PAG), anterior cingulate cortex, and prefrontal cortex (Ellingsen et al., 2016).

• Attenuation of Central Sensitization: Restoring normal segmental biomechanics resolves aberrant mechanical stress, reducing the continuous peripheral inflammatory and nociceptive cascades that drive central sensitization and microglial activation.

• Sympathovagal Balance: Spinal adjustments help balance the autonomic nervous system by down-regulating sympathetic drive and enhancing parasympathetic outflow. This shifts the patient away from the sustained fight-or-flight state characteristic of post-acute withdrawal.

Diagnostic Framework: DSM-5-TR and Whole-Person Assessment

A complete clinical assessment bridges structural diagnosis with psychiatric and behavioral staging. The Diagnostic and Statistical Manual of Mental Disorders (5th ed., text rev.; DSM-5-TR; American Psychiatric Association, 2022) organizes OUD symptoms into four primary domains:

• Impaired Control: Escalation of use, failed attempts to taper, cravings, and excessive time spent procuring or recovering from opioids.

• Social Impairment: Deterioration of occupational performance, interpersonal strain, and abandonment of vital recreational pursuits.

• Risky Use: Continued use despite known physical pathology or hazardous environments.

• Pharmacologic Adaptation: Manifestation of tolerance and neurobiological withdrawal.

       DSM-5-TR Structural Staging
 ??????????????????????????????????????????
 ? Mild: 2–3 Criteria Present             ?
 ? Moderate: 4–5 Criteria Present         ?
 ? Severe: 6+ Criteria Present            ?
 ??????????????????????????????????????????
                     ?
                     ?
      Whole-Person Clinical Evaluation
 ??????????????????????????????????????????
 ? • Biomechanical & Postural Mapping     ?
 ? • Co-occurring Mood & PTSD Screening   ?
 ? • Infectious Disease Panels (HIV/HCV)  ?
 ? • Sleep Architecture & Autonomic Tone  ?
 ? • Social Determinants & Trauma History ?
 ??????????????????????????????????????????

In integrated clinical practice, diagnostic checkboxes are translated into structural, physical realities. A history of childhood trauma or complex adverse childhood experiences (ACEs) frequently manifests somatically as hypertonic paraspinal musculature, chronic pelvic tilting, altered gait mechanics, and cervicogenic headaches. Evaluating biomechanics alongside DSM-5-TR criteria enables clinicians to identify structural pain drivers before escalating medication regimens.

Medications for Opioid Use Disorder: The Therapeutic Base

While manual therapy resolves biomechanical dysfunction, pharmacotherapy provides the biochemical stability patients need to engage in rehabilitation safely and effectively (Wakeman & Rich, 2018).

                      Pharmacological Comparison of MOUD
???????????????????????????????????????????????????????????????????????????????????????????????
? Attribute     ? Methadone           ? Buprenorphine            ? Extended-Release Naltrexone?
???????????????????????????????????????????????????????????????????????????????????????????????
? Mechanism     ? Full mu-agonist     ? Partial mu-agonist       ? Full mu-antagonist         ?
? Affinity      ? Moderate            ? Very high; slow off-rate ? High                       ?
? Respiratory   ? Linear dose-        ? Ceiling effect protects  ? None; blocks exogenous     ?
? Risk          ? dependent depression? against fatal arrest     ? opioids                    ?
? Regulatory    ? Certified OTP       ? Standard DEA authority   ? Standard pharmacy;         ?
? Model         ? facilities only     ? (office-based)           ? REMS protocols apply       ?
? Ideal Patient ? Severe tolerance,   ? Broad community care,    ? Completed detoxification,  ?
? Profile       ? failed prior bup    ? fentanyl exposure, pain  ? co-occurring alcohol use   ?
???????????????????????????????????????????????????????????????????????????????????????????????

Buprenorphine Dynamics

Buprenorphine remains the cornerstone of office-based addiction medicine. Its high receptor affinity displaces full agonists (such as illicit fentanyl or oxycodone). At the same time, its partial intrinsic activity activates the receptor enough to quell autonomic withdrawal and intense cravings without triggering full euphoria. Because its G-protein signaling plateau caps respiratory suppression, buprenorphine provides an exceptional safety profile.

In patients presenting with co-occurring chronic musculoskeletal conditions, divided daily dosing (e.g., administering buprenorphine every 6 to 8 hours rather than once daily) harnesses its 6-to-8-hour analgesic window. This maintains steady, therapeutic pain relief and steady receptor occupancy throughout the day.

Avoiding Precipitated Withdrawal

In communities saturated with lipophilic, illicit fentanyl analogs, traditional inductions carry a risk of precipitated withdrawal if initiated too early. When patients cannot tolerate the moderate withdrawal threshold required for standard initiation (Clinical Opiate Withdrawal Scale [COWS] score of 9 to 12), clinicians utilize low-dose microdosing induction protocols (e.g., the Bernese method).

Day 1:  0.25 mg SL once daily   ? Full agonist maintained at baseline
Day 2:  0.25 mg SL twice daily  ? Full agonist maintained at baseline
Day 3:  0.5 mg SL twice daily   ? Full agonist maintained at baseline
Day 4:  1.0 mg SL twice daily   ? Full agonist maintained at baseline
Day 5:  2.0 mg SL twice daily   ? Full agonist maintained at baseline
Day 6:  4.0 mg SL twice daily   ? Full agonist maintained at baseline
Day 7:  8.0 mg SL in morning    ? Full agonist discontinued completely
Day 8+: 16.0 mg SL maintenance  ? Titrate to clinical stability (16–24 mg/day)

Long-acting subcutaneous injectables (such as Sublocade or Brixadi) maintain stable serum levels over weeks or months. This eliminates the daily peak-and-trough cycle, removes the cognitive burden of daily dosing, and minimizes medication diversion.

Chiropractic Clinical Practice in OUD: Modulating Pain and Secondary Comorbidities

Patients with active OUD or those on long-term agonist maintenance face unique biomechanical and somatic challenges. Dr. Jimenez’s observations at Health Voice 360 demonstrate how targeted chiropractic care resolves specific musculoskeletal patterns and their secondary comorbidities:

        Primary Musculoskeletal Driver & Integrated Solution
???????????????????????????????????????????????????????????????????????????????????????????
? Clinical Presentation      ? Underlying Pathophysiology  ? Chiropractic & Manual Target ?
???????????????????????????????????????????????????????????????????????????????????????????
? Severe Myofascial Spasm &  ? Noradrenergic rebound       ? Gentle mobilization, dry     ?
? Post-Acute Cramping        ? causing diffuse motor tone  ? needling, and trigger point  ?
?                            ? hyper-excitability          ? ischemic compression         ?
? Kinetic Asymmetry &        ? Antalgic guarding and       ? Pelvic-sacral leveling,      ?
? Lumbar Spine Dysfunction   ? core muscular deconditioning? drop-table sacroiliac repair,?
?                            ? from sedentary periods      ? graded core reactivation     ?
? Chronic Sympathetic Strain ? Chronic stress axis firing, ? Suboccipital decompression,  ?
? & Cervicogenic Headaches   ? postural collapse, and      ? upper thoracic mobilization, ?
?                            ? structural kinetic distortion? breathing retraining         ?
? Peripheral Entrapment &    ? Prolonged static compression? Neurodynamic nerve flossing, ?
? Neural Tension Syndromes   ? during drug-induced stupor  ? extremity adjustments, myofascial?
?                            ? or unyielding sleep states  ? release along path           ?
???????????????????????????????????????????????????????????????????????????????????????????

Deconstructing Musculoskeletal Pain Syndromes in OUD

1. Withdrawal-Induced Paraspinal Spasm: During acute or protracted withdrawal, the abrupt loss of exogenous opioid tone causes noradrenergic rebound throughout the spinal cord. Paraspinal muscles contract into sustained, painful spasms. High-velocity manual adjustments, combined with instrument-assisted soft tissue mobilization (IASTM), restore mechanoreceptor firing, interrupt sustained motor neuron discharge, and relieve debilitating pain without additional medications.

2. Postural Deconditioning and Pelvic Distortion: Prolonged sedentary periods during active drug use alter pelvic posture, leading to hip flexor contractures, gluteal amnesia, and sacroiliac joint dysfunction. Chiropractic corrections realign the pelvic basin, equalize leg-length discrepancies, and decompress facet joints, directly removing the structural source of mechanical low back pain.

3. Compression Neuropathies and Nerve Entrapments: Individuals recovering from drug overdoses or periods of prolonged immobility often present with nerve entrapments (such as radial, peroneal, or sciatic neuropraxias) caused by sustained external pressure. Gentle manual peripheral nerve decompression, coupled with passive range-of-motion routines, restores normal axoplasmic transport and speeds functional recovery.

Alleviating Secondary Comorbidities

• Sleep Disruption and Insomnia: Chronic spinal misalignment and muscular hypertonicity prevent comfortable sleep posturing, worsening the fragmented sleep patterns common during buprenorphine stabilization. Restoring spinal joint mobility relieves nocturnal discomfort, allowing patients to reach restorative slow-wave sleep.

• Autonomic and Gastrointestinal Dysmotility: Both chronic opioid use and partial agonist therapies can slow gastrointestinal transit and cause pelvic floor hypertonia. Thoracolumbar and sacral spinal adjustments help modulate the visceral autonomic plexuses, easing functional constipation and abdominal guarding when paired with dietary guidance and regular hydration.

• Kinesiophobia and Fear-Avoidance Beliefs: Patients with a history of OUD often fear movement, worrying that any structural pain will trigger an unmanageable relapse. By guiding patients through safe, controlled joint mobilization and progressive rehabilitation, chiropractors help desensitize the nervous system, rebuild movement confidence, and break the fear-avoidance cycle.

Harm Reduction, Collaborative Communication, and Clinical Workflows

Safe, effective clinical care pairs biomechanical rehabilitation with harm reduction and patient-centered communication.

                  Primary Care Harm Reduction Protocol
???????????????????????????????????????????????????????????????????????????????????????????????????????
? Naloxone Co-Prescribing         ? Drug Checking Technology        ? SSP Integration                 ?
???????????????????????????????????????????????????????????????????????????????????????????????????????
? Universal co-prescription of    ? Fentanyl & xylazine test strips ? Warm handoffs to verified local ?
? 4 mg intranasal spray with      ? supplied directly to patients   ? Syringe Services Programs for   ?
? step-by-step family response    ? alongside clear, non-stigmatizing? sterile equipment, testing, and ?
? instructions                    ? education on supply testing     ? community-based linkage         ?
???????????????????????????????????????????????????????????????????????????????????????????????????????

The Spirit of Motivational Interviewing

Conversations in the exam room either build trust or drive patients away. Motivational Interviewing (MI) approaches treatment as a collaboration, respecting patient autonomy rather than issuing top-down directives (Miller & Rollnick, 2013).

Traditional Directive Approach           Motivational Interviewing Approach
"You must stop using illicit opioids    ? "What are your primary goals for your health
or we cannot treat your back pain."      ? right now, and how can we manage your pain
                                         ? safely so you can meet them?"
                                         ?
"Your compliance with this program       ? "You were able to come to your appointment
is entirely unsatisfactory."             ? today despite severe withdrawal symptoms.
                                         ? What strengths helped you make it in?"

Reflective listening lowers defensiveness, reduces sympathetic tone, and eases somatic guarding. This emotional safety helps patients engage openly with both their physical rehabilitation plans and their medical addiction therapies.

Integrated Rehabilitation Architecture

Achieving long-term recovery requires breaking the link between physical discomfort and chemical self-medication. Combining non-pharmacologic physical therapies, lifestyle adjustments, and targeted pain neuroscience education creates a sustainable foundation for lasting health.

       Integrated Biopsychosocial Recovery Framework
 ???????????????????????????????????????????????????????????????
 ? Pain Neuroscience Education (PNE)                           ?
 ? • Reframes pain as a protective alarm, not tissue damage    ?
 ? • Dispels fears surrounding normal bodily sensations        ?
 ???????????????????????????????????????????????????????????????
                                ?
                                ?
 ???????????????????????????????????????????????????????????????
 ? Restorative Biomechanical Care                              ?
 ? • Chiropractic manipulation and joint mobilization         ?
 ? • Passive soft-tissue therapies and neurodynamic flossing   ?
 ???????????????????????????????????????????????????????????????
                                ?
                                ?
 ???????????????????????????????????????????????????????????????
 ? Active Functional Rehabilitation                            ?
 ? • Core stabilization, isometric holds, and functional moves ?
 ? • Graded exercise therapy tailored to baseline tolerance    ?
 ???????????????????????????????????????????????????????????????
                                ?
                                ?
 ???????????????????????????????????????????????????????????????
 ? Autonomic and Lifestyle Optimization                        ?
 ? • Vagal nerve stimulation, diaphragmatic breathing routines ?
 ? • Circadian alignment, balanced nutrition, and hydration    ?
 ???????????????????????????????????????????????????????????????

Pain Neuroscience Education

Clinicians teach patients that pain is an adaptable protective response modulated by the nervous system, rather than a direct indicator of tissue damage. This understanding lowers catastrophic thinking, eases kinesiophobia, and decreases the perceived need for full mu-agonist analgesics during rehabilitation.

Progressive Physical Rehabilitation

Once chiropractic adjustments restore joint mechanics and reduce nociceptive input, patients transition to progressive physical rehab. Low-load isometric stabilization exercises progress into dynamic functional movement patterns. Building physical resilience restores independence, improves endurance, and reinforces personal agency throughout recovery.

References

• American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.).

• Centers for Disease Control and Prevention. (2023). U.S. overdose deaths involving fentanyl and other synthetic opioids.

• Ellingsen, D. M., Napadow, V., Protsenko, E., Mawla, I., Kowalski, M. H., Swensen, D., Osgood, P., & Kaptchuk, T. J. (2016). Brain mechanisms of manual therapy: A systematic review and meta-analysis of neuroimaging studies. Pain, 157(11), 2415–2428.

• Jimenez, A. (2026). Clinical perspectives on integrative primary care, functional rehabilitation, and addiction medicine. Health Voice 360.

• Jimenez, A. (2026). Professional clinical profile and practice focus. LinkedIn.

• Jones, C. M., Compton, W. M., & Volkow, N. D. (2018). The converging crises of opioids and stimulants. The New England Journal of Medicine, 378(9), 785–787.

• Koob, G. F., & Volkow, N. D. (2016). Neurobiology of addiction: A neurocircuitry analysis. The Lancet Psychiatry, 3(8), 760–773.

• Larochelle, M. R., Bernson, D., Land, T., Stopka, T. J., Wang, N., Xuan, Z., Bagley, S. M., Liebschutz, J. M., & Walley, A. Y. (2018). Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: A cohort study. Annals of Internal Medicine, 169(3), 137–145.

• Miller, W. R., & Rollnick, S. (2013). Motivational interviewing: Helping people change (3rd ed.). The Guilford Press.

• Pickar, J. G. (2002). Neurophysiological effects of spinal manipulation. The Spine Journal, 2(5), 357–371.

• Substance Abuse and Mental Health Services Administration. (2021). TIP 63: Medications for opioid use disorder. U.S. Department of Health and Human Services.

• Wakeman, S. E., & Rich, J. D. (2018). The opioid crisis: A path forward. The New England Journal of Medicine, 378(8), 693–695.

opioid use disorder, chiropractic care for OUD, musculoskeletal pain, chronic pain management, buprenorphine, methadone, harm reduction, spinal manipulation, neurobiology of pain, Dr. Alexander Jimenez, Health Voice 360, integrative addiction medicine, central sensitization, subluxation, physical medicine and rehabilitation, nonpharmacologic pain relief, DSM-5-TR, naloxone, fentanyl